Yang, A., Shi, J., Luo, Y., Ye, Y., Tan, Y., Huang, H., & Zhao, Y. (2019). Allo-HSCT recipients with invasive fungal disease and ongoing immunosuppression have a high risk for developing tuberculosis. Sci Rep.
Styl cytowania ChicagoYang, Apeng, Jimin Shi, Yi Luo, Yishan Ye, Yamin Tan, He Huang, i Yanmin Zhao. "Allo-HSCT Recipients With Invasive Fungal Disease and Ongoing Immunosuppression Have a High Risk for Developing Tuberculosis." Sci Rep 2019.
Styl cytowania MLAYang, Apeng, et al. "Allo-HSCT Recipients With Invasive Fungal Disease and Ongoing Immunosuppression Have a High Risk for Developing Tuberculosis." Sci Rep 2019.
Uwaga: Te cytaty mogą odróżniać się od wytycznej twojego fakultetu..